News · Vaccines
595 stories
Aug 6, 26Opinion: What my colleagues and I will look for as we assess U.S. measles elimination status
Aug 5, 26Earnings roundup: Gilead’s ‘uncertain’ future, Pfizer’s crossroads and Merck’s PCSK9 launch
Jul 29, 26Earnings roundup: Biogen’s ‘resiliency,’ AstraZeneca’s growth pitch and GSK’s oncology push